Gill David N
SEC-identified person · CIK 1106519 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Telix Pharmaceuticals Ltd TLX | Director | filed 2026 - 2026 |
| Evolus, Inc. EOLS) | Director | filed 2018 - 2026 |
| Y-Mabs Therapeutics, Inc. YMAB | Director | filed 2018 - 2025 |
| Strongbridge Biopharma plc SBBP | Director | filed 2019 - 2021 |
| Strata Skin Sciences, Inc. SSKN | Director | filed 2018 - 2019 |
| Melinta Therapeutics, INC. /NEW/ MLNT | Director | filed 2012 - 2019 |
| Ocugen, Inc. OCGN | Director | filed 2015 - 2018 |
| Endochoice Holdings, Inc. GI | See remarks. | filed 2015 - 2016 |
| Isotis INC ISOT | Director | filed 2007 - 2007 |
| Lemaitre Vascular INC LMAT | Director | filed 2006 - 2007 |
| Idleaire Technologies Corp | Director | filed 2006 - 2006 |
| Nxstage Medical, Inc. NXTM | SVP & CFO | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.